Healius (ASX:HLS) Pre-Tax Income : A$-995 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Healius Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Healius's pretax income for the six months ended in Dec. 2023 was A$-640 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-995 Mil. Healius's pretax margin was -75.34%.

During the past 13 years, Healius's highest Pretax Margin was 17.85%. The lowest was -58.83%. And the median was 3.22%.

Healius Pre-Tax Income Historical Data

The historical data trend for Healius's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Pre-Tax Income Chart

Healius Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

83.20

46.40

167.80

416.90

-397.30

Healius Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															336.40	80.50	-41.70	-355.60	-639.60

Competitive Comparison of Healius's Pre-Tax Income

For the Diagnostics & Research subindustry, Healius's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Healius's Pre-Tax Income Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Healius's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Healius's Pre-Tax Income falls into.

Healius Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Healius's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	98.1	+	-433.1	+	-28.6	+	0	+	-33.7
	=	-397

Healius's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	0.6	+	-604.2	+	-16.2	+	0	+	-19.8
	=	-640

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-995 Mil.

Healius (ASX:HLS) Pre-Tax Income Explanation

Healius's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-639.6	/	849
	=	-75.34%

During the past 13 years, Healius's highest Pretax Margin was 17.85%. The lowest was -58.83%. And the median was 3.22%.

Healius Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Healius's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Healius (ASX:HLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000

Website

https://www.healius.com.au

Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius (ASX:HLS) Headlines

No Headlines